Investors
Curative Biotechnology, Inc., (CUBT) formerly known as ConnectyxTechnologies Holding Group, Inc. (CTYX) was founded in 2007. New management assumed control in February 2020.The Company changed the name and trading symbol in the first quarter of 2021.
Curative Biotech is headquartered at:
3801 PGA Blvd, Suite 600
Palm Beach Gardens, FL 33410
Curative Biotech shares currently trade on the OTC Markets Group under the symbol “CUBT” for common shares.
Curative Biotech does not offer a direct stock purchase program.
Curative Biotech’s fiscal year ends on December 31.
Curative Biotech OTC filings, including its annual report, quarterly earnings releases and other investor materials are available under the “Investors” section of our corporate website.
Additionally, all OTC filings can also be accessed directly from the OTC Markets website at: Filings and Disclosure
Curative Biotech does not anticipate paying any cash dividends in the foreseeable future.
The transfer agent and registrar for Curative Biotech is:
Issuer Direct Corporation,
500 Perimeter Park Drive, Suite D,
Morrisville, NC 27560.
919-481-4000
www.issuerdirect.com